ACE2 and infection: In lung cells, SARS-CoV-2 uses the serine protease TMPRSS2 to initiate the receptor-binding domain (RBD) of its S-protein, binding to the ACE2 of the host cells and promoting entry; the virus subsequently releases RNA in the cytoplasm for replications, causing infection symptoms [9,10,11].